Is OMER A Good Stock To Buy Now?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW).
Omeros Corp (OMER)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 48,032,000 | $36,303 | -27% | 0.84% | |
| 2. | 27,709,000 | $20,505 | 0.63% | ||
| 3. | 15,500,000 | $13,976 | 0.01% | ||
| 4. | D E Shaw D. E. Shaw | 1,836,487 | $11,037 | -5% | 0.01% |
| 5. | 14,500,000 | $10,818 | 0.37% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $12.68 | 3,962 | Director | 185,182 | 2015-09-04 | Filing | |
| $16.20 | 6,153 | Director | 181,220 | 2014-06-24 | Filing | |
| $5.72 | 40,000 | Director | 186,872 | 2013-01-04 | Filing | |
| $5.58 | 2,000 | Director | 2,400 | 2013-01-03 | Filing | |
| $5.42 | 9,345 | Director | 175,067 | 2013-01-03 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $14.90 | 36,857 | 2,026,986 | 2021-06-17 | Filing | ||
| $15.02 | 36,856 | 2,026,986 | 2021-06-15 | Filing | ||
| $14.96 | 36,856 | 2,026,986 | 2021-05-20 | Filing | ||
| $17.07 | 36,857 | 2,026,986 | 2021-05-19 | Filing | ||
| $17.76 | 35,206 | 2,026,986 | 2021-04-08 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 97,288 | $584,701 | 0% | |
| 2. | 44,932 | $270,040 | 0% | |
| 3. | 36,780,000 | $27,056 | 0.03% | |
| 4. | 4,205,090 | $25,273 | 1.12% | |
| 5. | 4,065,401 | $24,434 | 0% |
News See All
Hedge Funds Are Buying Omeros Corporation (OMER)
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Hedge Funds Aren’t Crazy About Omeros Corporation (OMER) Anymore
Last year's fourth quarter was a rough one for investors and many hedge funds, which were naturally unable to overcome the big dip in the broad market, as the S&P 500 fell by about 4.8% during 2018 and...
Were Hedge Funds Right About Warming Up To Omeros Corporation (OMER)?
At Insider Monkey we track the activity of some of the best-performing hedge funds like Appaloosa Management, Baupost, and Tiger Global because we determined that some of the stocks that they are collectively...
Did Hedge Funds Drop The Ball On Omeros Corporation (OMER) ?
Before we spend days researching a stock idea we'd like to take a look at how hedge funds and billionaire investors recently traded that stock.
Market Movers Today: Omeros Corporation (OMER), AbbVie Inc (ABBV), Darden Restaurants, Inc. (DRI), Odyssey Marine Exploration Inc (OMEX), and More
Omeros Corp. OMER, +36.60% shares surged 45% in extremely heavy morning trade Thursday on a new government spending bill that benefits its cataract surgery drug Omidria.
32 Major Stories That You Should Read From the World of Finance Today
"The U.S. stock market Wednesday was on pace to log its worst daily decline in eight months, as concerns about President Donald Trump's FBI controversy weighed on investor sentiment.
Omeros Corporation (OMER) Stock: Gaining On Positive Study Results
Omeros Corporation (NASDAQ:OMER) is having an incredible day in the market today, and for good reason.
Here’s Why Zynerba Pharmaceuticals, Kratos Defense, Rogers Communications, and Two Other Stocks Are on Investors’ Radars Today
Stocks are in the red on Monday following Fed Chair Janet Yellen’s speech on Friday, in which she said the US economy is still facing the reverberations of 2008-2009 crisis, which can only be undone...
Do Hedge Funds Love Omeros Corporation (OMER)?
The third quarter was a rough one for most investors, as fears of an interest rate hike in the U.S, a weakening economy in China, and a stagnant Europe, weighed heavily on the minds of investors.
Billionaire Hedge Funds
